English
Home > Products > 307-34-6

China 307-34-6 Factory

Our items are commonly identified and trusted by people and can fulfill repeatedly altering economic and social wants of 307-34-6,CAS NO 307-34-6,Perfluorooctane, We generally concertrating on creating new creative item to meet request from our clients everywhere in the world. Be a part of us and let's make driving safer and funnier alongside one another!
307-34-6, Further, we're supported by highly experienced and knowledgeable professionals, who have immense expertise in their respective domain. These professionals work in close coordination with each other to provide our clients an effective range of products and solutions.

Related Products

Hot Products

  • SAMARIUM

    SAMARIUM

    Product Name:SAMARIUM
    Molecular Formula:Sm
    Molecular Weight:150.36
    CAS Registry Number:7440-19-9
  • 5-Bromoacetyl-2-hydroxybenzaldehyde

    5-Bromoacetyl-2-hydroxybenzaldehyde

    Product Name:5-Bromoacetyl-2-hydroxybenzaldehyde
    Molecular Formula:C9H7BrO3
    Molecular Weight:243.05
    CAS Registry Number:115787-50-3
  • Pravastatin sodium

    Pravastatin sodium

    Product Name:Pravastatin sodium
    Molecular Formula:C23H36NaO7
    Molecular Weight;447.52
    CAS Registry Number;81131-70-6
  • N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine

    N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine

    Product Name:N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine
    Molecular Formula:C12H15FN2O3
    Molecular Weight:254.26
    CAS Registry Number:1289942-66-0
  • 3,5-Difluoropyridine-2,6-diamine

    3,5-Difluoropyridine-2,6-diamine

    Product Name:3,5-Difluoropyridine-2,6-diamine
    Molecular Formula:C5H5F2N3
    Molecular Weight:145.11
    CAS Registry Number:247069-27-8
  • Potassium sulfate

    Potassium sulfate

    Product Name:Potassium sulfate
    Molecular Formula:K2O4S
    Molecular Weight:174.2592
    CAS Registry Number;13647-35-3
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 307-34-6

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept